Records containing: Relapsed or Refractory B Cell Leukemia and Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-06A Single-arm, Open-label Clinical Study on the Safety and Preliminary Efficacy of in Vivo CAR-T (U96) in the Treatment of Relapsed/Refractory B-cell Tumors
-
CLINICAL_TRIALS study record update · 2025-02-19Safety and Efficacy of CAR2219 CAR-T Cells in Treatment of Relapsed/refractory CD19/CD22 Positive B Cell Leukemia and Lymphoma